Company Filing History:

9 out of 346

Richter Gedeon Vegyeszeti Gyar Rt

patents

4 out of 240

The Administrators of the Tulane Educational Fund

patents

3 out of 13

Gyogyszerkutato Intezet Kft.

5. 1 out of 832,680

Other

patents

Years Active: 1976-2003

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6593300 - (3R)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta (2003-07-15),

2. 6214969 - Luteinizing hormone releasing hormone analogs with cytotoxic moiety (2001-04-10),

3. 6121241 - Anticoagulant peptide aldehyde derivatives (2000-09-19),

4. 5760235 - Anticoagulant peptide derivatives and pharmaceutical compositions (1998-06-02),

5. 5258492 - LHRH analogues with cytotoxic moieties at the sixth position (1993-11-02),

6. 5198533 - LHRH antagonists (1993-03-30),

7. 4914189 - Synthetic GHRH analogs (1990-04-03),

8. 4800191 - LHRH antagonists (1989-01-24),

9. 4703036 - Peptide-aldehydes, process for the preparation thereof and (1987-10-27),

10. 4478745 - T-Butyloxy-carbonyl-D-phenylalanyl-L-prolyl-L-arginine aldehyde (1984-10-23),

11. 4465625 - Pentapeptides and process for their preparation (1984-08-14),

12. 4399065 - D-Phenylalanyl-L-prolyl-L-arginine aldehyde sulfate and process for the (1983-08-16),

13. 4346078 - Novel anticoagulant agmatine derivatives and process for the preparation (1982-08-24),

14. 4339440 - Enkephalin analogs and a process for the preparation thereof (1982-07-13),

15. 4316889 - Novel peptidyl-arginine aldehyde derivatives and process for the (1982-02-23),

Title: Innovations and Contributions of Inventor Sandor Bajusz

Introduction

Sandor Bajusz is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry and has been granted 18 patents throughout his career. His innovative work primarily focuses on developing compounds that have profound implications for medical treatments.

Latest Patents

Among his recent patents, Sandor Bajusz has developed (3R)-3-amino-4-carboxybutyraldehyde derivatives which inhibit the release of interleukin-1/beta. Additionally, he has introduced Luteinizing hormone-releasing hormone (LHRH) analogs that contain cytotoxic moieties. These analogs not only influence the release of gonadotropins from the pituitary in mammals but also possess antineoplastic effects. These compounds are characterized by a complex formula that includes various amino acids and cytotoxic moieties, demonstrating the intricate designs involved in his inventions.

Career Highlights

Throughout his professional journey, Sandor has been associated with reputable companies, including Richter Gedeon Vegyeszeti Gyar Rt and The Administrators of the Tulane Educational Fund. His work in these institutions has been instrumental in advancing pharmaceutical research and innovation.

Collaborations

Sandor Bajusz has collaborated with esteemed professionals in his field, such as Eva Barabas and Daniel Bagdy. These collaborations have further enriched his research and have contributed to the successful development of his patented inventions.

Conclusion

In summary, Sandor Bajusz stands out as a prominent inventor with a robust portfolio of patents highlighting his innovative approach to pharmaceutical chemistry. His contributions continue to impact the medical field positively, showcasing the importance of research and development in creating effective treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.